Back to Resource Center

Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control

Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control

December 2018

Click to view Press Release

Click for full info +

Full Info:

Resource Type:

Citation:

(2018, December 17). Evofem Biosciences.

Health Risks(s):

STI / STD
Unintended Pregnancy

Product type(s):

Contraceptives
Hormonal
MPTs
VaginalCream

Topic(s):

MPTs
Development

URL of resource:

https://evofem.investorroom.com/2018-12-17-Evofem-Biosciences-Announces-Positive-Top-Line-Results-of-Phase-3-Study-Evaluating-Amphora-for-Hormone-Free-Birth-Control

Back to Resource Center